Effect of Myofascial Release on Dysphagia in Parkinson's Patients
Trial
N/A
Unknown
March 14, 2024
Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
Trial
Phase 4
Completed
March 12, 2024
Cognition and Obstructive Sleep Apnea in Parkinson's Disease, Effect of Positive Airway Pressure Therapy
Trial
N/A
Completed
March 12, 2024
ARC Intellicare for Telerehabilitation
Trial
N/A
Completed
March 12, 2024
Treatment of Apomorphine-induced Skin Reactions: a Pilot Study
Trial
Phase 2
Terminated
March 12, 2024
Clinical, Molecular and Electrophysiological Profiling of Parkinson's Disease: the Role of Non-pharmacological Therapies
Trial
N/A
Unknown
March 12, 2024
A Study Assessing the Effects of Acupuncture in Parkinson's Disease Patients With Chronic Appendicitis
Trial
N/A
Recruiting
March 11, 2024
Cardiovascular Effects of Exercise in Patients With Parkinson's Disease
Trial
N/A
Unknown
March 11, 2024
The Effect of Simple Gymnastics Training for Parkinson's Patients in the Community
Trial
N/A
Withdrawn
March 11, 2024
Effectiveness of Stellate Ganglion Block in Individuals With Parkinson's Disease
Trial
N/A
Unknown
March 11, 2024
The Efficacy of VESPA 2.0 for Cognitive Rehabilitation in Patients With Mild Cognitive Impairment
Trial
N/A
Completed
March 7, 2024
Impulse Control Disorder Among Parkinson's Disease Patients
Trial
N/A
Unknown
March 7, 2024
Rasagiline Tablets Special Drug Use-Results Survey "Survey on Long-term Safety"
Trial
N/A
Completed
March 7, 2024
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
Trial
N/A
Unknown
March 7, 2024
Characterization and Progression of Minor Phenomena in Parkinson's Disease (PD)
Trial
N/A
Completed
March 7, 2024
Safety and Efficacy of Liraglutide in Parkinson's Disease
Trial
Phase 2
Completed
March 6, 2024
Parkinson's Disease and Gamma-transcranial Alternating Current Stimulation
Trial
N/A
Unknown
March 6, 2024
Algorithm Guided DBS Programming in Parkinson's Patients
Trial
N/A
Recruiting
March 5, 2024
A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
Trial
Phase 2
Completed
March 5, 2024